NOVARTIS FARMA PRODUTOS FARMACEUTICOS, SA secures contract for Acquisition Of Omalizumab 150 Mg/1 Ml Sol Inj Ser 1 Ml Sc

Portugal, Aug. 26 -- Portugal based NOVARTIS FARMA PRODUTOS FARMACEUTICOS, SA has secured contract from Unidade Local De Saude De Sao Jose, E. P. E. for Acquisition Of Omalizumab 150 Mg/1 Ml Sol Inj Ser 1 Ml Sc. The value of the contract is worth 11931750 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....